Stanislav Glezer insider trades: Inogen (INGN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stanislav reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 1, 2022 | INGN | ↓ Sell | 1,576 | $28.16 | $44K | Direct | Sep 6, 2022 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other INGN insiders
Open-market trades in the last 12 months
About Stanislav Glezer's insider trades
Stanislav Glezer is EVP, R&D & Chief Med. Officer at Inogen (INGN). Since Sep 1, 2022, Stanislav has reported no open-market purchases and 1 sale worth $44K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (8 filings), shares withheld for taxes (7 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.